Barrington Research Cuts Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSICFree Report) – Investment analysts at Barrington Research lowered their Q1 2025 earnings per share (EPS) estimates for shares of Henry Schein in a research report issued to clients and investors on Thursday, January 30th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings per share of $1.06 for the quarter, down from their previous estimate of $1.12. Barrington Research currently has a “Outperform” rating and a $90.00 price target on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Barrington Research also issued estimates for Henry Schein’s Q2 2025 earnings at $1.20 EPS, Q3 2025 earnings at $1.22 EPS, Q4 2025 earnings at $1.37 EPS and FY2025 earnings at $4.85 EPS.

A number of other analysts have also issued reports on HSIC. Evercore ISI lifted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Mizuho began coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Seven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $80.10.

Get Our Latest Analysis on HSIC

Henry Schein Trading Up 0.2 %

Shares of HSIC opened at $80.03 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a one year low of $63.67 and a one year high of $82.63. The stock has a 50-day moving average price of $73.31 and a 200 day moving average price of $71.34. The company has a market capitalization of $9.98 billion, a P/E ratio of 32.93, a P/E/G ratio of 2.20 and a beta of 0.89.

Henry Schein (NASDAQ:HSICGet Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.32 EPS.

Insider Activity at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at $6,577,950. The trade was a 12.25 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 1.14% of the company’s stock.

Institutional Investors Weigh In On Henry Schein

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Allworth Financial LP increased its stake in Henry Schein by 180.7% in the 4th quarter. Allworth Financial LP now owns 946 shares of the company’s stock worth $71,000 after purchasing an additional 609 shares in the last quarter. Figure 8 Investment Strategies LLC acquired a new stake in Henry Schein during the 4th quarter valued at $538,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in shares of Henry Schein in the fourth quarter worth $2,281,000. Quent Capital LLC grew its holdings in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares in the last quarter. Finally, Equitable Trust Co. acquired a new position in Henry Schein during the fourth quarter valued at $417,000. 96.62% of the stock is owned by institutional investors and hedge funds.

About Henry Schein

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.